The researchers examined data from adults ages 18-64 living in 11 high-income countries across three years. Americans had the highest rate of people responding that they skipped medications due to cost, with only 10 percent of Australians and fewer than five percent of U.K. residents saying the same.
The U.S. also ranked higher than the other 10 countries involved in the study for drug unaffordability among adults over 65.
More articles on pharmacy:
Eli Lilly to test COVID-19 antibody drug in nursing homes
Politicians should stay out of COVID-19 vaccine approval, health experts warn
Sanofi, GlaxoSmithKline under investigation for possible carcinogen in Zantac
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
